Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF vs G-CSF + GM-CSF for Stem Cell Mobilization in NHL
NCT00499343Phase 2Completed
- Sponsor
- University of Texas MD Anderson Cancer Center
- Start
- Jan 2004
- Primary completion
- Oct 2008
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of sargramostim in non-Hodgkin lymphoma (NHL), sponsored by University of Texas MD Anderson Cancer Center. Started Jan 2004; status: completed.
02
Drugs
sargramostim
03
Conditions
non-Hodgkin lymphoma (NHL)
Beyond the preview
Go deeper on NCT00499343.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00499343.